MATINAS BIOPHARMA HOLDINGS I (MTNB) Stock Analyst Ratings
NYSEARCA:MTNB - NYSE Arca - US5768103039 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 46% to MTNB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 30.6. This target is 3236.24% above the current price.
MTNB was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about MTNB.
In the previous month the buy percentage consensus was at a similar level.
MTNB was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-31 | Maxim Group | Downgrade | Buy -> Hold |
| 2023-10-11 | BTIG | Reiterate | Buy -> Buy |
| 2023-01-31 | HC Wainwright & Co. | Reiterate | Buy |